EH71 Dermatoses precipitated by drug therapy International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Specific dermatoses which are not in themselves commonly associated with drugs but which may be precipitated in susceptible individuals by certain drugs.
code elsewhere postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed [select] EA00 Viral exanthem due to unknown or unspecified agent EA0Y Viral exanthem due to other specified virus EA10 Pityriasis rosea EA11 Papular purpuric gloves and socks syndrome EA12 Infantile papular acrodermatitis EA20 Necrolytic acral erythema EA3Z Unspecified skin disorder attributable to viral infection EA40 Tropical phagedaenic ulcer EA50 Toxin-mediated cutaneous reactions to distant or systemic bacterial infection EA50.0 Erythema marginatum rheumaticum EA50.1 Streptococcal toxin-mediated perineal erythema EA50.2 Staphylococcal scalded skin syndrome EA50.3 Staphylococcal scarlatina EA50.Y Other specified toxin-mediated cutaneous reactions to distant or systemic bacterial infection EA50.Z Toxin-mediated cutaneous reactions to distant or systemic bacterial infection, unspecified EA51 Skin complications of BCG immunisation EA5Y Cutaneous involvement by other specified bacterial infection EA5Z Cutaneous involvement by unspecified bacterial infection EA60 Certain skin disorders attributable to fungal infection EA60.0 Subcutaneous mycoses EA60.1 Systemic mycoses affecting skin EA60.Y Skin involvement in other specified fungal infection EA60.Z Fungal infection of the skin, unspecified EA6Y Cutaneous involvement by other specified infection or infestation EA80 Atopic eczema EA80.0 Infantile atopic eczema EA80.1 Childhood atopic eczema EA80.2 Adult atopic eczema EA80.Y Other specified forms of atopic eczema EA80.Z Atopic eczema, unspecified EA81 Seborrhoeic dermatitis and related conditions EA81.0 Seborrhoeic dermatitis of face EA81.1 Seborrhoeic dermatitis of the scalp EA81.Y Seborrhoeic dermatosis of other specified type or distribution EA81.Z Seborrhoeic dermatitis, unspecified EA82 Nummular dermatitis EA83 Lichen simplex or lichenification EA83.0 Lichen simplex EA83.1 Secondary lichenification – EA83.00 Lichen simplex of vulva – EA83.01 Lichen simplex of male genitalia – EA83.02 Perianal lichen simplex – EA83.0Y Lichen simplex of other specified site – EA83.0Z Lichen simplex of unspecified site EA84 Asteatotic eczema EA85 Dermatitis or eczema of hands and feet EA85.0 Vesicular dermatitis of hands and feet EA85.1 Hyperkeratotic dermatitis of hands and feet EA85.2 Dermatitis of hands EA85.3 Dermatitis of feet – EA85.20 Atopic eczema of hands – EA85.2Y Other specified dermatitis of hands – EA85.2Z Dermatitis of hands, unspecified EA86 Dermatitis and eczema of lower legs EA86.0 Stasis dermatitis of the lower legs EA87 Dermatitis or eczema of anogenital region EA87.0 Dermatitis or eczema of male genitalia EA87.1 Dermatitis or eczema of female genitalia EA87.2 Dermatitis or eczema of perianal area EA87.Z Dermatitis or eczema of anogenital region, unspecified EA88 Miscellaneous specified eczematous dermatoses EA88.0 Infectious dermatitis EA88.1 Post traumatic eczema EA88.2 Disseminated secondary eczema EA88.3 Secondary eczema EA88.4 Pityriasis alba – EA88.00 Human T-cell lymphotropic virus type 1 associated infective dermatitis of childhood – EA88.0Y Other specified infectious dermatitis – EA88.0Z Infectious dermatitis, unspecified EA89 Generalised eczematous dermatitis of unspecified type EA8Y Other specified eczematous dermatosis EA8Z Dermatitis or eczema, unspecified EA90 Psoriasis EA90.0 Plaque psoriasis EA90.1 Guttate psoriasis EA90.2 Unstable psoriasis EA90.3 Erythrodermic psoriasis EA90.4 Pustular psoriasis EA90.5 Psoriasis of specified site or distribution EA90.Y Other specified forms of psoriasis EA90.Z Psoriasis of unspecified type – EA90.40 Generalised pustular psoriasis – EA90.41 Acropustulosis of Hallopeau – EA90.42 Palmoplantar pustulosis – EA90.4Y Other specified pustular psoriasis – EA90.4Z Pustular psoriasis, unspecified – EA90.50 Scalp psoriasis – EA90.51 Nail psoriasis – EA90.52 Flexural and intertriginous psoriasis – EA90.53 Anogenital psoriasis – EA90.5Y Psoriasis of other specified site or distribution EA91 Lichen planus EA91.0 Acute eruptive lichen planus EA91.1 Hypertrophic lichen planus EA91.2 Follicular lichen planus EA91.3 Lichen planus of genital skin and mucous membranes EA91.4 Lichen planus and lichenoid reactions of oral mucosa EA91.5 Lichen planus of the nails EA91.6 Subacute lichen planus EA91.Y Other specified lichen planus EA91.Z Lichen planus of unspecified type – EA91.40 Non-erosive lichen planus of oral mucosa – EA91.41 Erosive oral lichen planus – EA91.42 Oral lichen planus, unspecified – EA91.43 Lichenoid mucositis – EA91.4Y Other specified lichenoid reactions of oral mucosa EA92 Lichenoid dermatoses EA93 Pityriasis lichenoides EA94 Pityriasis rubra pilaris EA95 Small plaque parapsoriasis EB00 Spontaneous urticaria EB00.0 Acute urticaria EB00.1 Chronic urticaria EB00.Z Spontaneous urticaria, unspecified EB01 Inducible urticaria and angioedema EB01.0 Dermographism EB01.1 Cold urticaria EB01.2 Delayed pressure urticaria EB01.3 Contact urticaria EB01.Y Other specified forms of inducible urticaria and angioedema EB01.Z Inducible urticaria and angioedema, unspecified EB02 Cholinergic urticaria and related conditions EB02.0 Cholinergic urticaria EB02.Y Other conditions mediated by cholinergic activation EB03 Syndromes with urticarial reactions or angioedema EB04 Idiopathic angioedema EB05 Urticaria of unspecified type EB0Y Other specified urticarial disorders EB10 Diffuse inflammatory erythemas EB11 Annular erythema EB12 Erythema multiforme EB12.0 Cutaneous erythema multiforme EB12.1 Mucocutaneous erythema multiforme EB12.Y Other specified erythema multiforme EB12.Z Erythema multiforme, unspecified EB13 Stevens-Johnson syndrome or toxic epidermal necrolysis EB13.0 Stevens-Johnson syndrome EB13.1 Toxic epidermal necrolysis EB13.2 Stevens-Johnson and toxic epidermal necrolysis overlap syndrome EB20 Acute febrile neutrophilic dermatosis EB21 Pyoderma gangrenosum EB2Y Other specified neutrophilic dermatoses EB30 Eosinophilic cellulitis EB31 Erythema nodosum EB40 Pemphigus EB40.0 Pemphigus vulgaris EB40.1 Pemphigus foliaceus EB40.2 Paraneoplastic pemphigus EB40.Y Other specified pemphigus EB40.Z Pemphigus, unspecified – EB40.00 Oral pemphigus – EB40.0Y Other specified pemphigus vulgaris – EB40.0Z Pemphigus vulgaris, unspecified EB41 Pemphigoid EB41.0 Bullous pemphigoid EB41.1 Mucous membrane pemphigoid EB41.Y Other specified pemphigoid EB41.Z Pemphigoid, unspecified EB42 Linear IgA bullous dermatosis EB43 Epidermolysis bullosa acquisita EB44 Dermatitis herpetiformis EB4Y Other specified immunobullous disorder EB50 Subacute cutaneous lupus erythematosus EB51 Chronic cutaneous lupus erythematosus EB51.0 Discoid lupus erythematosus EB51.Y Other specified chronic cutaneous lupus erythematosus EB51.Z Chronic cutaneous lupus erythematosus, unspecified EB5Z Cutaneous lupus erythematosus of unspecified type EB60 Lichen sclerosus EB60.0 Lichen sclerosus of vulva EB60.1 Lichen sclerosus of penis EB60.Y Lichen sclerosus of other specified sites EB60.Z Lichen sclerosus, unspecified EB61 Morphoea EB61.0 Plaque morphoea EB61.1 Linear morphoea EB61.Y Other specified forms of morphoea EB61.Z Morphoea, unspecified EB7Y Other specified inflammatory dermatoses EB90 Dermatoses resulting from disturbed metabolic processes EB90.0 Diabetic skin lesions EB90.1 Cutaneous mucinosis EB90.2 Cutaneous and subcutaneous xanthomata EB90.3 Porphyria or pseudoporphyria affecting the skin EB90.4 Calcification of skin or subcutaneous tissue EB90.10 Pretibial myxoedema EB90.11 Lichen myxoedematosus EB90.12 Reticular erythematous mucinosis EB90.1Y Other specified forms of cutaneous mucinosis EB90.20 Plane xanthoma EB90.21 Tuberous xanthoma EB90.22 Eruptive xanthoma EB90.23 Tendinous xanthoma EB90.24 Xanthoma due to specified disorder of lipid metabolism EB90.2Z Cutaneous and subcutaneous xanthomata of unspecified type EB90.30 Pseudoporphyria EB90.3Y Other specified porphyria or pseudoporphyria affecting the skin EB90.40 Dystrophic calcification of the skin of uncertain or unspecified aetiology EB90.41 Calcific panniculitis EB90.42 Calcific arteriolopathy EB90.4Y Other specified calcification of skin or subcutaneous tissue EB9Y Other specified metabolic and nutritional disorders affecting the skin EC10 Genetic syndromes with poikiloderma EC1Y Other specified genetic syndromes affecting the skin EC20 Genetic disorders of keratinisation EC20.0 Non-syndromic ichthyosis EC20.1 Hereditary skin peeling EC20.2 Hereditary acantholytic dermatoses EC20.3 Hereditary palmoplantar keratodermas EC20.Y Other specified genetic disorders of keratinisation EC20.00 Ichthyosis vulgaris EC20.01 X-linked ichthyosis EC20.02 Autosomal recessive congenital ichthyosis EC20.03 Keratinopathic ichthyoses EC20.0Y Other specified or unclassifiable non-syndromic ichthyosis EC20.30 Diffuse palmoplantar keratodermas EC20.31 Focal palmoplantar keratodermas EC20.32 Papular palmoplantar keratodermas EC20.3Z Hereditary palmoplantar keratoderma of unspecified type EC21 Genetic defects of hair or hair growth EC21.0 Genetic defects of the hair shaft EC21.1 Genetic syndromes with abnormalities of the hair shaft EC21.2 Hereditary alopecia or hypotrichosis EC21.3 Genetic syndromes with alopecia or hypotrichosis EC21.4 Genetically-determined hypertrichosis EC21.Y Other specified genetic defects of hair or hair growth EC21.Z Genetic defects of hair or hair growth, unspecified EC22 Genetic defects of nails or nail growth EC22.0 Inherited deformities of nails EC23 Genetic disorders of skin pigmentation EC23.0 Non-syndromic genetically-determined hypermelanosis or lentiginosis EC23.1 Syndromic genetically-determined hypermelanosis or lentiginosis EC23.2 Albinism or other specified genetically-determined hypomelanotic disorders EC23.Y Other specified genetic disorders of skin pigmentation EC23.Z Genetic disorders of skin pigmentation, unspecified EC23.20 Oculocutaneous albinism EC23.2Y Other specified genetically-determined hypomelanotic disorders EC30 Epidermolysis bullosa simplex EC31 Junctional epidermolysis bullosa EC32 Dystrophic epidermolysis bullosa EC33 Syndromic epidermolysis bullosa EC3Z Epidermolysis bullosa EC40 Pseudoxanthoma elasticum EC4Y Other specified genetic disorders affecting dermal matrix proteins EC50 Developmental anomalies of the umbilicus EC5Y Other specified developmental anomalies affecting the skin EC7Y Other specified genetic and developmental disorders affecting the skin EC90 Pruritus EC90.0 Pruritus due to skin disorder EC90.1 Pruritus due to systemic disorder EC90.2 Drug-induced pruritus EC90.3 Pruritus due to neurological disorder EC90.4 Psychogenic pruritus EC90.5 Anogenital pruritus EC90.6 Pruritus of unknown cause EC90.Y Pruritus of other specified type or aetiology EC90.Z Pruritus, unspecified – EC90.10 Uraemic pruritus – EC90.11 Cholestatic pruritus – EC90.12 Haemodialysis-associated pruritus – EC90.1Y Pruritus due to other specified systemic disorder EC91 Prurigo EC91.0 Nodular prurigo EC91.1 Atopic prurigo EC91.Z Prurigo, unspecified EC92 Mucocutaneous or cutaneous pain syndromes EC92.0 Penoscrotodynia EC92.1 Scalp dysaesthesia EC9Y Other specified disturbances of cutaneous sensation ED00 Artefactual skin disorder ED01 Simulated skin disease ED02 Painful bruising syndrome ED0Y Other specified self-inflicted skin disorders ED2Y Other specified mental conditions affecting the skin ED30 Neuropathic skin damage ED30.0 Neuropathic skin ulceration ED30.Y Other specified neuropathic skin damage ED31 Burning feet syndrome ED3Y Cutaneous involvement in other specified neurological condition ED50 Ichthyoses – ED50.0 Acquired ichthyosis – ED50.Z Ichthyosis of unspecified type ED51 Diffuse epidermal hyperkeratosis and acanthosis – ED51.0 Acanthosis nigricans – ED51.Y Other specified hyperkeratotic and acanthotic dermatoses –– ED51.00 Benign acanthosis nigricans –– ED51.0Y Other specified acanthosis nigricans –– ED51.0Z Acanthosis nigricans, unspecified ED52 Porokeratoses ED53 Skin peeling ED54 Xerosis cutis or asteatosis ED55 Palmoplantar keratodermas – ED55.0 Acquired palmoplantar keratodermas – ED55.Z Palmoplantar keratoderma, unspecified ED56 Keratosis pilaris ED5Y Other specified disorders of epidermal keratinisation ED60 Acquired hypermelanosis – ED60.0 Physiological hypermelanosis – ED60.1 Melasma – ED60.2 Postinflammatory hypermelanosis – ED60.Y Hypermelanosis of other specified aetiology – ED60.Z Hypermelanosis of unspecified aetiology –– ED60.00 Suntan –– ED60.01 Tanning due to exposure to artificial sources of ultraviolet radiation ED61 Acquired melanotic macules or lentigines – ED61.0 Freckles – ED61.1 Mucosal melanosis – ED61.Y Other specified acquired melanotic macules or lentigines –– ED61.10 Penile melanotic macule –– ED61.11 Vulval melanotic macule –– ED61.1Y Other specified mucosal melanosis ED62 Endogenous non-melanin pigmentation – ED62.0 Haemosiderin pigmentation of skin – ED62.Y Other specified endogenous non-melanin pigmentation ED63 Acquired hypomelanotic disorders – ED63.0 Vitiligo – ED63.1 Hypomelanosis due to exposure to chemicals – ED63.2 Postinflammatory hypomelanosis – ED63.3 Vogt-Koyanagi-Harada syndrome – ED63.Y Acquired hypomelanosis due to other specified disorder – ED63.Z Acquired hypomelanosis of unknown or unspecified aetiology ED64 Abnormal skin pigmentation ED6Y Other specified disorders of skin pigmentation ED70 Alopecia or hair loss – ED70.0 Male pattern hair loss – ED70.1 Female pattern hair loss – ED70.2 Alopecia areata – ED70.3 Telogen effluvium – ED70.4 Anagen effluvium – ED70.5 Scarring alopecia – ED70.Y Other specified alopecia or hair loss – ED70.Z Alopecia, unspecified –– ED70.20 Patchy alopecia areata of scalp –– ED70.21 Alopecia totalis –– ED70.2Y Other specified forms of alopecia areata –– ED70.2Z Alopecia areata, unspecified –– ED70.30 Acute telogen effluvium –– ED70.31 Postpartum telogen effluvium –– ED70.3Y Telogen hair shedding due to other specified cause –– ED70.3Z Telogen effluvium unspecified –– ED70.50 Folliculitis decalvans –– ED70.51 Dissecting cellulitis –– ED70.5Y Scarring alopecia due to other specified cause –– ED70.5Z Scarring alopecia of unknown or unspecified aetiology ED71 Hypertrichosis ED72 Hirsutism and syndromes with hirsutism – ED72.0 Constitutional hirsutism – ED72.1 Hirsutism associated with hyperandrogenaemia – ED72.Z Hirsutism, unspecified ED73 Acquired disorders of the hair shaft – ED73.0 Weathered hair – ED73.1 Acquired changes in hair colour – ED73.Y Other specified acquired disorders of the hair shaft –– ED73.10 Premature canities –– ED73.11 Acquired poliosis ED7Y Other specified disorders of hair – ED80 Acne –– ED80.0 Comedonal acne –– ED80.1 Superficial mixed comedonal and papulopustular acne –– ED80.2 Papulopustular acne –– ED80.3 Nodular acne –– ED80.4 Severe inflammatory acne –– ED80.5 Acne scarring –– ED80.6 Infantile acne –– ED80.Y Other specified acne –– ED80.Z Acne, unspecified ––– ED80.40 Acne fulminans ––– ED80.41 Acne conglobata ––– ED80.4Y Other specified severe inflammatory acne ––– ED80.4Z Severe inflammatory acne, unspecified – ED81 Acneform inflammatory disorders –– ED81.0 Folliculitis cruris pustulosa atrophicans –– ED81.1 Acneform reactions to halogenated aromatic hydrocarbons –– ED81.Y Other specified acneform inflammatory disorders ED90 Rosacea and related disorders – ED90.0 Rosacea – ED90.1 Periorificial dermatitis – ED90.Y Other specified rosacea-like disorders – ED90.Z Rosacea-like disorders unspecified –– ED90.00 Erythematotelangiectatic rosacea –– ED90.01 Papulopustular rosacea –– ED90.02 Phymatous rosacea –– ED90.0Y Other specified rosacea –– ED90.0Z Rosacea, unspecified ED91 Disorders of the sebaceous gland – ED91.0 Heterotopic sebaceous glands – ED91.1 Sebaceous gland hyperplasia – ED91.2 Seborrhoea – ED91.Y Other specified disorders of the sebaceous gland – ED91.Z Disorders of the sebaceous gland, unspecified ED92 Disorders involving the apocrine follicular unit – ED92.0 Hidradenitis suppurativa – ED92.1 Apocrine sweat disorders – ED92.Y Other specified disorders involving the apocrine follicular unit – ED92.Z Disorders involving the apocrine follicular unit, unspecified ED9Y Other specified disorders involving the hair follicle EE00 Hyperhidrosis – EE00.0 Localised hyperhidrosis – EE00.1 Primary generalised hyperhidrosis – EE00.Z Hyperhidrosis, unspecified –– EE00.00 Palmoplantar hyperhidrosis –– EE00.01 Axillary hyperhidrosis –– EE00.02 Craniofacial hyperhidrosis –– EE00.0Y Other specified localised hyperhidrosis –– EE00.0Z Localised hyperhidrosis, unspecified EE01 Hypohidrosis – EE01.0 Hypohidrosis attributable to defective sudomotor innervation or function – EE01.1 Hypohidrosis due to genetic abnormalities of eccrine gland structure or function – EE01.2 Hypohidrosis of undetermined aetiology – EE01.Y Other specified forms of hypohidrosis – EE01.Z Hypohidrosis, unspecified EE02 Miliaria – EE02.0 Neonatal miliaria – EE02.Y Other specified forms of miliaria – EE02.Z Miliaria, unspecified EE0Y Other specified disorders of eccrine sweat glands or sweating EE10 Acquired deformities of the nail plate – EE10.0 Abnormality of nail shape – EE10.1 Abnormality of nail surface – EE10.2 Onycholysis – EE10.3 Nail hypertrophy – EE10.4 Nail atrophy – EE10.5 Nail dystrophy, not otherwise specified – EE10.Y Other specified acquired deformities of the nail plate – EE10.Z Acquired deformities of the nail plate, unspecified –– EE10.10 Nail pitting –– EE10.1Y Other specified abnormality of nail surface –– EE10.1Z Abnormality of nail surface, unspecified EE11 Acquired abnormalities of nail colour – EE11.0 Melanonychia – EE11.1 Yellow nail syndrome – EE11.Y Other abnormalities of nail colour – EE11.Z Acquired abnormalities of nail colour, unspecified EE12 Infections of the nail or perionychium – EE12.0 Acute bacterial paronychia – EE12.1 Onychomycosis – EE12.Y Other specified infections of the nail or perionychium – EE12.Z Infections of the nail or perionychium, unspecified EE13 Certain disorders affecting the nails or perionychium – EE13.0 Nail fragility – EE13.1 Ingrowing nail – EE13.2 Chronic paronychia – EE13.3 Nail disorder associated with specified dermatosis – EE13.4 Nail disorder associated with specified systemic disease – EE13.5 Eczematous nail dystrophy – EE13.Y Other specified nail disorder –– EE13.10 Ingrowing toenail –– EE13.11 Infected ingrowing toenail –– EE13.1Y Other specified ingrowing nail –– EE13.1Z Ingrowing nail, unspecified EE1Y Other specified disorders of the nail or perionychium EE1Z Disorders of the nail or perionychium, unspecified EE20 Acute cutaneous distension syndrome EE21 Epidermal fragility EE40 Atrophy or degeneration of dermal or subcutaneous connective tissue – EE40.0 Corticosteroid-induced skin atrophy – EE40.1 Stretch marks – EE40.2 Atrophic scarring of the skin – EE40.3 Skin fragility – EE40.Y Other specified atrophy or degeneration of dermal or subcutaneous connective tissue – EE40.Z Atrophy or degeneration of dermal or subcutaneous connective tissue, unspecified type –– EE40.10 Stretch marks of pregnancy –– EE40.1Y Stretch marks of other specified aetiology –– EE40.1Z Stretch marks, unspecified –– EE40.30 Genetically-determined skin fragility –– EE40.31 Age-related skin fragility –– EE40.32 Purpura or bruising due to vascular fragility EE41 Abnormalities of dermal elastin – EE41.0 Cutis laxa – EE41.1 Anetoderma – EE41.Y Other specified dermatoses characterised by abnormal dermal elastin – EE41.Z Abnormalities of dermal elastin, unspecified – EE50 Acquired poikiloderma – EE60 Keloid or hypertrophic scars –– EE60.0 Keloid –– EE60.1 Hypertrophic scar –– EE60.Y Other specified keloidal disorders ––– EE60.00 Ear-lobe keloid ––– EE60.0Y Other specified keloid ––– EE60.0Z Keloid, unspecified – EE61 Superficial fibromatoses – EE6Y Other specified fibromatous disorders of skin and soft tissue EE70 Perforating dermatoses – EE70.0 Acquired perforating dermatosis – EE70.Y Other specified perforating dermatoses – EE70.Z Perforating dermatoses, unspecified EE7Y Other specified disorders of cutaneous connective tissue EE80 Necrobiotic granulomatous skin disorders – EE80.0 Granuloma annulare – EE80.1 Necrobiosis lipoidica – EE80.Z Necrobiotic granulomatous skin disorders, unspecified EE81 Dermal dendrocyte, Class IIa histiocytoses EE8Y Other specified histiocytic and granulomatous disorders of the skin EE90 Benign lymphocytic infiltration of the skin EE91 Lymphocytoma cutis EF00 Panniculitis – EF00.0 Pancreatic enzyme panniculitis – EF00.Y Panniculitis of other specified aetiology – EF00.Z Panniculitis of undetermined or unspecified etiology EF01 Lipoatrophy or lipodystrophy – EF01.0 Acquired partial lipodystrophy – EF01.1 Localised lipoatrophy and lipodystrophy – EF01.Y Other specified forms of lipodystrophy and lipoatrophy – EF01.Z Lipodystrophy of unspecified type EF02 Certain noninflammatory disorders of subcutaneous fat – EF02.0 Fat hypertrophy – EF02.1 Subcutaneous lipomatosis – EF02.2 Lipoedema – EF02.3 Cellulite – EF02.Y Other specified noninflammatory disorders of subcutaneous fat – EF02.Z Noninflammatory disorders of subcutaneous fat, unspecified EF0Y Other specified disorders of subcutaneous fat EF20 Acquired malformations of cutaneous blood vessels – EF20.0 Venous lake – EF20.1 Angiokeratoma – EF20.2 Lower limb venous telangiectases – EF20.3 Spider telangiectasis – EF20.4 Generalised essential telangiectasia – EF20.Y Other specified acquired malformations of cutaneous blood vessels – EF20.Z Acquired malformations of cutaneous blood vessels, unspecified EF2Z Cutaneous vascular malformation, unspecified EF30 Purpura or bruising due to disorders of coagulation EF31 Traumatic purpura EF3Y Other specified purpura EF3Z Purpura of unspecified aetiology EF40 Vasculitis or capillaritis involving the skin EF40.0 Capillaritis EF40.1 Vasculitis affecting small cutaneous blood vessels EF40.2 Localised cutaneous vasculitis EF40.Z Cutaneous vasculitis unspecified – EF40.10 Urticarial vasculitis – EF40.1Y Other specified vasculitis affecting small cutaneous blood vessels – EF40.20 Granuloma faciale – EF40.2Y Other specified localised cutaneous vasculitis EF50 Livedoid vasculopathy EF5Y Other specified dermatoses attributable to hyperviscosity or microvascular occlusion EF60 Ischaemic ulceration of skin – EF70 Lower limb venous eczema – EF7Y Other specified dermatoses due to venous disease – EF7Z Dermatoses due to venous disease, unspecified EF9Y Other specified dermatoses resulting from vascular insufficiency EG00 Vasodilatation of extremities EG01 Vasoconstriction of extremities EG02 Flushing disorders EG30 Skin disorders localised to the scalp EG30.0 Scalp folliculitis EG30.1 Erosive pustular dermatosis of scalp EG30.2 Pityriasis amiantacea EG30.Y Other specified scalp disorders not elsewhere classifiable EG30.Z Skin disorders localised to the scalp, unspecified – EG40 Contact dermatitis of external ear –– EG40.0 Allergic contact dermatitis of external ear – EG4Y Other specified inflammatory disorder of external ear – EG4Z Inflammatory disorder of external ear, unspecified EG60 Anal pruritus EG61 Infections of the anus or perianal skin EG62 Inflammatory dermatoses of the perianal area EG63 Sacrococcygeal pilonidal disease – EG63.0 Sacrococcygeal pilonidal sinus – EG63.1 Sacrococcygeal pilonidal cyst – EG63.2 Sacrococcygeal pilonidal abscess – EG63.Z Sacrococcygeal pilonidal disease, unspecified EG7Y Other specified skin disorders involving the genital and perianal regions EG9Y Skin disorders involving other specific body regions EG9Z Skin disorders involving certain specific body regions, unspecified EH10 Neonatal viral infections involving the skin EH11 Neonatal pyogenic skin infections EH12 Neonatal fungal infections involving the skin EH1Z Neonatal skin infection, unspecified EH3Y Other specified skin disorders specific to the perinatal or neonatal period EH40 Dermatoses of infancy EH40.0 Infantile seborrhoeic dermatitis EH40.1 Infantile napkin dermatoses EH40.2 Erythrodermas of infancy EH40.3 Acute haemorrhagic oedema of infancy EH40.Y Other specified dermatoses of infancy EH40.Z Dermatoses of infancy, unspecified EH40.00 Cradle cap EH40.01 Disseminated infantile seborrhoeic dermatitis EH40.02 Psoriasiform napkin dermatitis EH40.0Z Infantile seborrhoeic dermatitis, unspecified EH40.10 Primary irritant napkin dermatitis EH40.1Y Other specified infantile napkin dermatoses EH40.1Z Infantile napkin dermatoses, unspecified EK70 Cutaneous cysts EK70.0 Epidermoid cyst EK70.1 Trichilemmal cyst EK70.2 Digital myxoid pseudocyst EK70.3 Hidrocystoma EK70.Y Other specified cutaneous cysts EK70.Z Cutaneous cysts, unspecified EK70.00 Infected epidermoid cyst EK70.0Z Epidermoid cyst, unspecified EK71 Skin tags or polyps EK71.0 Fibroepithelial polyp of skin EK71.1 Multiple skin tags EK71.Z Polyp of skin not elsewhere classified EK90 Actinic keratosis and other discrete epidermal dysplasias EK90.0 Actinic keratosis EK90.1 Diffuse actinic keratinocyte dysplasia EK90.Y Other discrete epidermal dysplasias EK91 Dermatoses which may presage cutaneous lymphoma EK91.0 Large plaque parapsoriasis EK91.1 Poikiloderma vasculare atrophicans EK91.2 Primary cutaneous plasmacytosis EK92 Histiocytoses of uncertain malignant potential EL10 Paraneoplastic syndromes involving skin EL1Y Other specified cutaneous markers of internal malignancy EL3Y Other specified cutaneous markers of internal disorders EL50 Unsatisfactory surgical scar of skin EL50.0 Keloidal surgical scar EL50.1 Hypertrophic surgical scar EL50.2 Atrophic surgical scar EL50.3 Expanded surgical scar EL50.Z Unsatisfactory surgical scar of skin, unspecified EL51 Cutaneous flap necrosis EL52 Myocutaneous flap necrosis EL53 Skin graft failure EL54 Composite graft failure EL60 Acute radiodermatitis following radiotherapy EL61 Chronic radiodermatitis following radiotherapy EL63 Radionecrosis of skin due to therapeutic ionizing irradiation EL73 Unsatisfactory outcome from cutaneous cosmetic surgical procedure EL73.0 Adverse reaction to dermal or deep fillers EL73.1 Adverse reaction to chemical peel EL73.2 Adverse reaction to injection of neurotoxin EL73.3 Unsatisfactory outcome from cosmetic laser surgery EL73.4 Hypomelanosis resulting from cosmetic procedure EL73.5 Dyspigmentation resulting from cosmetic procedure EL73.6 Fibrosis or scarring following cosmetic procedure EL80 Adverse cutaneous effects of diagnostic procedures NE81.00 Haematoma of surgical wound of skin NE81.20 Superficial incisional site infection EL50 Unsatisfactory surgical scar of skin EL50.0 Keloidal surgical scar EL50.1 Hypertrophic surgical scar EL50.2 Atrophic surgical scar EL50.3 Expanded surgical scar EL50.Z Unsatisfactory surgical scar of skin, unspecified EL51 Cutaneous flap necrosis EL52 Myocutaneous flap necrosis EL53 Skin graft failure EL54 Composite graft failure EL73.3 Unsatisfactory outcome from cosmetic laser surgery EK02.23 Irritant contact dermatitis related to stoma or fistula KC50 Neonatal phototherapy burn EL60 Acute radiodermatitis following radiotherapy EL61 Chronic radiodermatitis following radiotherapy EL63 Radionecrosis of skin due to therapeutic ionizing irradiation EL73 Unsatisfactory outcome from cutaneous cosmetic surgical procedure EL73.0 Adverse reaction to dermal or deep fillers EL73.1 Adverse reaction to chemical peel EL73.2 Adverse reaction to injection of neurotoxin EL73.3 Unsatisfactory outcome from cosmetic laser surgery EL73.4 Hypomelanosis resulting from cosmetic procedure EL73.5 Dyspigmentation resulting from cosmetic procedure EL73.6 Fibrosis or scarring following cosmetic procedure – EC90.12 Haemodialysis-associated pruritus EL80 Adverse cutaneous effects of diagnostic procedures PB20 Unintentional exposure to or harmful effects of opioids or related analgesics PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants PB22 Unintentional exposure to or harmful effects of psychostimulants PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PB25 Unintentional exposure to or harmful effects of antidepressants PB26 Unintentional exposure to or harmful effects of antipsychotics PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances PB30 Unintentional exposure to or harmful effects of alcohols PB31 Unintentional exposure to or harmful effects of organic solvents PB32 Unintentional exposure to or harmful effects of carbon monoxide PB33 Unintentional exposure to or harmful effects of pesticides PB34 Unintentional exposure to or harmful effects of corrosive substances PB35 Unintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons PB36 Unintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified PL0Z Substances associated with injury or harm in therapeutic use, unspecified PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.0 Overdose of substance, as mode of injury or harm PL13.1 Underdosing, as mode of injury or harm PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm PL13.3 Incorrect substance, as mode of injury or harm PL13.5 Incorrect administration of drug or medicament, as mode of injury PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm PL13.9 Drug or substance interactions, as mode of injury or harm PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified PL13.50 Incorrect route of drug or medicament, as mode of injury PL13.51 Incorrect rate of drug or medicament, as mode of injury PL13.52 Incorrect timing of drug or medicament, as mode of injury PL13.53 Incorrect duration of drug or medicament, as mode of injury PL13.5Y Other specified incorrect administration of drug or medicament, as mode of injury PL13.5Z Incorrect administration of drug or medicament, as mode of injury, unspecified
synonyms Dermatoses precipitated by drug therapy Blistering dermatoses precipitated by drug therapy Immunobullous dermatosis classified elsewhere precipitated by drug
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com